Paper7842013
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.
Kaplitt MG and 6 others. Nat Genet, 1994. Cited by 891 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Papers, record 7842013. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7842013
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.
- PubMed
Topics28
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain | Major topic |
| Dependovirus | Major topic |
| Gene Expression Regulation, Viral | Major topic |
| Genetic Therapy | Major topic |
| Genetic Vectors | Major topic |
| Parkinson Disease, Secondary | Major topic |
| Recombinant Fusion Proteins | Major topic |
| Tyrosine 3-Monooxygenase | Major topic |
| Adenoviruses, Human | |
| Animals | |
| Apomorphine | |
| Behavior, Animal | |
| Corpus Striatum | |
| Cytomegalovirus | |
| Genes, Reporter | |
| Genes, Synthetic | |
| Helper Viruses | |
| Humans | |
| Male | |
| Microinjections | |
| Oxidopamine | |
| Promoter Regions, Genetic | |
| Rats | |
| Rats, Sprague-Dawley | |
| Simian virus 40 | |
| Substantia Nigra | |
| Transfection | |
| beta-Galactosidase |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| HL48347 | NHLBI NIH HHS | United States | R01HL048347 | PubMed and NIH |
Source NIH RePORTER
Cited by305
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 891 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42589500 | AAV Vectors in Regenerative Medicine and Cellular Reprogramming: Potential, Pitfalls, and Specificity Constraints. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589500 | PubMed |
| 42056501 | AAV2 capsid clearance and neuronal trafficking dynamics in the central nervous system. | Gene Ther | 2026 | https://conductscience.org/library/papers/42056501 | PubMed |
| 41542629 | Dynamic control of Raf-ERK signaling modulates neuronal activity across biological scales. | bioRxiv | 2026 | https://conductscience.org/library/papers/41542629 | PubMed |
| 40542144 | AAV for ovarian cancer gene therapy. | Cancer Gene Ther | 2025 | https://conductscience.org/library/papers/40542144 | PubMed |
| 40538303 | Exploring AAV-Mediated Gene Therapy for Inner Ear Diseases: from Preclinical Success to Clinical Potential. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40538303 | PubMed |
| 40454374 | Advances in viral vector-based delivery systems for gene therapy: a comprehensive review. | 3 Biotech | 2025 | https://conductscience.org/library/papers/40454374 | PubMed |
| 40186350 | AAV vector development, back to the future. | Mol Ther | 2025 | https://conductscience.org/library/papers/40186350 | PubMed |
| 40181545 | The road toward AAV-mediated gene therapy of Duchenne muscular dystrophy. | Mol Ther | 2025 | https://conductscience.org/library/papers/40181545 | PubMed |
| 40022444 | Gene therapy then and now: A look back at changes in the field over the past 25 years. | Mol Ther | 2025 | https://conductscience.org/library/papers/40022444 | PubMed |
| 39901690 | Updates on the Pathogenesis and Therapeutic Approaches for Hereditary Hemorrhagic Telangiectasia. | Curr Vasc Pharmacol | 2025 | https://conductscience.org/library/papers/39901690 | PubMed |
| 39596149 | Adeno-Associated Viral Vectors in the Treatment of Epilepsy. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596149 | PubMed |
| 39383230 | Bidirectional regulation of motor circuits using magnetogenetic gene therapy. | Sci Adv | 2024 | https://conductscience.org/library/papers/39383230 | PubMed |
| 38830095 | Developmental hearing loss-induced perceptual deficits are rescued by genetic restoration of cortical inhibition. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38830095 | PubMed |
| 38543807 | Natural Adeno-Associated Virus Serotypes and Engineered Adeno-Associated Virus Capsid Variants: Tropism Differences and Mechanistic Insights. | Viruses | 2024 | https://conductscience.org/library/papers/38543807 | PubMed |
| 38256124 | Delivery of Adeno-Associated Virus Vectors to the Central Nervous System for Correction of Single Gene Disorders. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38256124 | PubMed |
| 38188726 | AAV for Gene Therapy in Ocular Diseases: Progress and Prospects. | Research (Wash D C) | 2023 | https://conductscience.org/library/papers/38188726 | PubMed |
| 38058618 | Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer. | Heliyon | 2023 | https://conductscience.org/library/papers/38058618 | PubMed |
| 37837522 | Synaptic configuration and reconfiguration in the neocortex are spatiotemporally selective. | Anat Sci Int | 2024 | https://conductscience.org/library/papers/37837522 | PubMed |
| 37753219 | Breaching the blood-brain barrier: AAV triggers dose-dependent toxicity in the brain. | Mol Ther Methods Clin Dev | 2023 | https://conductscience.org/library/papers/37753219 | PubMed |
| 37551863 | Gene therapy of adeno-associated virus (AAV) vectors in preclinical models of ischemic stroke. | CNS Neurosci Ther | 2023 | https://conductscience.org/library/papers/37551863 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GLB1 | 2720 | PubTator's text mining | https://conductscience.org/library/genes/2720 | NCBI Gene |
| TH | 7054 | PubTator's text mining | https://conductscience.org/library/genes/7054 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7842013
GET https://conductscience.org/api/papers/v1/7842013/cited_by?page=2